Evidence map›Paper›PMID 39183827›Full record

ReviewHeliyon2024

Barriers to commercial deployment of biorefineries: A multi-faceted review of obstacles across the innovation chain.

Denzel Christopher Makepa, Chido Hermes Chihobo

Abstract readReview
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Denzel Christopher MakepaDepartment of Fuels and Energy Engineering, Chinhoyi University of Technology, Private Bag, 7724, Chinhoyi, Zimbabwe.
Chido Hermes ChihoboDepartment of Fuels and Energy Engineering, Chinhoyi University of Technology, Private Bag, 7724, Chinhoyi, Zimbabwe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Realizing integrated biorefineries producing multiple fuels, chemicals and materials from sustainable biomass feedstocks holds promise for transitioning industries onto low-carbon trajectories. However, widespread commercial implementation remains elusive despite two decades of technological advancements. This review synthesizes current literature to provide a comprehensive analysis of key multi-dimensional barriers inhibiting the scale-up of biorefineries. The review discusses the technical challenges around biomass conversion processes. Economic viability concerns such as high capital costs and lack of market competitiveness are also assessed. The review also evaluates the regulatory and policy complexities that poses risks and uncertainties in the scaling up of biorefineries. Socio-political acceptance hurdles including community engagement and public perception are also reviewed. The interconnected nature of these challenges is emphasized and strategies are recommended to enable full potential realization, covering areas such as enhanced stakeholder collaboration, advanced process intensification, supportive policy frameworks, innovative financing models and strategic marketing initiatives. International pilots and cross-sectoral knowledge exchange are highlighted as priority enablers. In conclusion, this review synthesizes insights from extensive demonstration efforts to identify priorities and pathways for accelerating the global commercial transition towards sustainable biorefinery implementation. It aims to inform strategic decision-making and collaborative actions amongst stakeholders in research, industry and policy domains.

Indexed as

BioeconomyBioenergyBiorefineryInnovation barriersSustainability transitionsTechnology commercialization

Identifiers

PMID39183827
PMCPMC11341323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.